Читать книгу Nanotechnology in Medicine - Группа авторов - Страница 4

1 Chapter 1Figure 1.1 Nanoscale properties and allied benefits of nanomaterials in nano...Figure 1.2 Nanomaterial applications in tissue engineering and regenerative ...Figure 1.3 Consequences of environmental contact of nanoparticles.

2 Chapter 2Figure 2.1 Scheme of the productive chain of fossil‐based polymers.Figure 2.2 Biopolymers and building blocks obtained by fermentation.Figure 2.3 Chemical structure of (a) poly(ε‐caprolactone) (PCL), (b) poly(la...Figure 2.4 Main pathways of the metabolism of benzene and its derivatives in...Figure 2.5 Aerobic biodegradation pathways of aromatic compounds conducted b...

3 Chapter 3Figure 3.1 Methods for the synthesis of selenium nanoparticles.Figure 3.2 Toxic effects of selenium nanoparticles.

4 Chapter 4Figure 4.1 Scheme of AgNPs’ biosynthesis and stabilization using linden leav...Figure 4.2 Drug delivery systems based on nanomaterials which were tested to...Figure 4.3 (a, b) TEM micrographs of AgNPs biosynthesized from 10 and 5 ml o...Figure 4.4 SEM images of Tetrahymena sp. trophozoites, after 60 minutes of e...Figure 4.5 Morphology of P. marinus hypnospores before and after interaction...

5 Chapter 5Figure 5.1 Copper nanoparticles induced cellular apoptosis via mitochondrial...Figure 5.2 Important physicochemical factors affecting AuNP toxicity. Decrea...

6 Chapter 6Figure 6.1 Bioapplicability of mesoporous silica nanoparticles (MSNs).Figure 6.2 Safety evaluation parameters of mesoporous silica nanoparticles (...

7 Chapter 7Figure 7.1 Dialysis method.Figure 7.2 Solvent evaporation method.Figure 7.3 Nanoprecipitation method.Figure 7.4 Application of polymeric nanoparticles.Figure 7.5 Safety concern of polymeric nanoparticles.

8 Chapter 8Figure 8.1 A schematic illustration of iodinated CS‐Cu NP composite synthesi...Figure 8.2 A schematic illustration of the proposed mechanism of antibacteri...

9 Chapter 9Figure 9.1 (a and b) represent different configurations of solid‐core lipid ...Figure 9.2 Toxicity mechanisms of components of gene delivery nanocarriers. ...Figure 9.3 Structures of cationic lipids and ionizable cationic lipids evalu...Figure 9.4 Structures of a few cationic polymers evaluated/being evaluated i...

10 Chapter 10Figure 10.1 Types of lipid nanoparticles.Figure 10.2 Toxicity due to nanoparticles.

11 Chapter 11Figure 11.1 Illustrations of carriers nanoparticulated and surface’s functio...

12 Chapter 12Figure 12.1 Illustration of different layers of the skin and various routes ...Figure 12.2 Schematics of different types of nanoformulations used in topica...

13 Chapter 13Figure 13.1 Nanostructured drug delivery systems.Figure 13.2 Nanonutraceuticals – considerations for toxicity and safety asse...

14 Chapter 14Figure 14.1 Nanomaterial's exposure pathways.Figure 14.2 In silico analysis: a computational method for the evaluation of...Figure 14.3 Nanosafety strategy.

15 Chapter 15Figure 15.1 The number of studies on the regulation of biomedical nano‐produ...Figure 15.2 The number of studies on the regulation of biomedical nano‐produ...

16 Chapter 16Figure 16.1 Types of nanotechnology.Figure 16.2 Applications of nanotechnology.

17 Chapter 17Figure 17.1 Assessment of physicochemical attributes of nanomaterials using ...Figure 17.2 Components of safety and health programme.Figure 17.3 Overview of regulatory control over nanotechnology.Figure 17.4 Various regulatory agencies providing guidance on regulation of ...